Trademark: 90717653
Word
LAINGAX
Status
Pending
Status Code
732
Status Date
Thursday, November 2, 2023
Serial Number
90717653
Mark Type
4000
Filing Date
Tuesday, May 18, 2021
Published for Opposition
Tuesday, March 8, 2022

Trademark Owner History
Tanvex BioPharma, Inc. - Owner At Publication

Classifications
5 pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
LAING AX

Trademark Events
Nov 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2023
Sou Extension 3 Granted
Nov 2, 2023
Sou Extension 3 Filed
Nov 2, 2023
Sou Teas Extension Received
Apr 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2023
Sou Extension 2 Granted
Apr 17, 2023
Sou Extension 2 Filed
Apr 17, 2023
Sou Teas Extension Received
Nov 3, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 1, 2022
Sou Extension 1 Granted
Nov 1, 2022
Sou Extension 1 Filed
Nov 1, 2022
Sou Teas Extension Received
May 3, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 8, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 8, 2022
Published For Opposition
Feb 16, 2022
Notification Of Notice Of Publication E-Mailed
Jan 28, 2022
Approved For Pub - Principal Register
Jan 27, 2022
Assigned To Examiner
Aug 30, 2021
Preliminary/Voluntary Amendment - Entered
Aug 26, 2021
Assigned To Lie
May 24, 2021
Teas Voluntary Amendment Received
Aug 16, 2021
New Application Office Supplied Data Entered
May 21, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24